Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics
about
Quantitative Analysis of Axonal Branch Dynamics in the Developing Nervous SystemMyocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain developmentDysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases.Axon guidance by growth-rate modulation.Genome-wide scan for signatures of human population differentiation and their relationship with natural selection, functional pathways and diseasesIdentifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.Gene expression in the rodent brain is associated with its regional connectivity.Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Prefrontal-enriched SLIT1 expression in Old World monkey cortex established during the postnatal development.Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression.Interactogeneous: disease gene prioritization using heterogeneous networks and full topology scores.Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins.Circulating miRNA biomarkers for Alzheimer's diseaseCopy number variations in a population-based study of Charcot-Marie-Tooth diseaseThe dynamics of growth cone morphologyDecreased expression of axon-guidance receptors in the anterior cingulate cortex in autismKIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis.Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neuronsHsc70 chaperone activity underlies Trio GEF function in axon growth and guidance induced by netrin-1.Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic DiseasesThe atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons.VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation.Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic MuscleRETRACTED: A mathematical model explains saturating axon guidance responses to molecular gradients.Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration.The Caenorhabditis elegans microtubule minus-end binding homolog PTRN-1 stabilizes synapses and neurites.What does the developing brain tell us about neural diseases?FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.Therapeutic targeting of EPH receptors and their ligands.Eph receptors and ephrins: therapeutic opportunities.Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation.Proteoglycans and axon guidance: a new relationship between old partners.Detecting genetic association through shortest paths in a bidirected graph.Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence.Maternal Diabetes Alters Expression of MicroRNAs that Regulate Genes Critical for Neural Tube Development.
P2860
Q27316612-AFCEEF7A-FFFD-430C-BFAE-375521B0968EQ28585951-7BD7D24E-AD54-4F01-BBAA-7EEAF6817E50Q29347521-9D2D73F9-5238-49E4-8DA2-4462F70058D1Q30493779-564FF397-9E02-4799-920D-DE3735775145Q30914210-B18848A0-56E8-4220-ABE4-C3E67D77B407Q33833978-C193D0C6-1D07-478C-9BFE-758A9E62816FQ33846348-83A1B411-ABED-40FB-8125-99E329FD6E43Q33900841-5F0ED633-5C45-427D-BE35-C51BA78E6E17Q33905527-754F86CE-F350-467B-80EB-4676D94E4CA8Q34032608-28561BEB-58B1-483F-8C34-DF32F36C239EQ34116622-6D2A330A-9523-4EF1-A3B4-151D8553FCD3Q34157658-5DF2F247-6C2A-47B6-B569-222186C0DB5DQ34445123-4B60D9A6-9860-45D2-99B7-431081388B1FQ34490301-BC4FC81F-4A1C-4C1B-BE0B-4213D0EE2D20Q34573339-0066C434-65F9-49C9-9F26-665FFC724E15Q34904013-C2098812-E614-48CE-BA6F-835B8010FFE3Q35013000-B279C6D5-E58D-477F-858D-BE51E636554AQ35158578-7C437D51-92DD-48E4-9739-987677DD2D9FQ35225592-FA45FA05-7D01-4D86-B32C-BEAE2A3D3850Q35663729-99285B5F-6C4E-4B9D-8052-7CBA661E51E9Q35669383-CD0E9DD0-479A-492D-9B76-971B720B7462Q35984215-D4C588F9-25F8-49CB-90EF-03ACC47525BFQ36014654-E47907DF-47D7-49DC-A273-687DB8C56187Q36092441-2D89A597-FCA8-4764-A2DA-69BF71971F1AQ36125301-E17A4211-A355-4780-9A37-AD7A34D57F88Q36234834-AFBF8066-39E4-41C2-BF66-1F14F3ED6051Q36254139-F6408BE0-1345-4571-8F2B-734B9EC10104Q36585931-9F1546EC-97D2-4521-BAF8-797EE9BF254FQ36786588-EC5877D4-CE9C-479A-98B6-CB1D79F51284Q37596039-7D476218-83BB-4F2F-B49E-7D35F434A9AFQ38019563-3359D3AD-EECB-4C93-9A9D-DC322F3E7B39Q38131381-AD678054-E23E-4F1E-B5FA-FE93961BB56EQ38174793-A5E270F0-3575-4650-ADDE-5AD467526AF2Q38257853-B26D0B60-3064-4C18-8C77-AAF01283EC47Q38503809-AB25EFEA-F08A-414B-9146-27FA85FCA997Q38680940-54EE0201-0DEB-437E-ADF6-0B54B3DC95A4Q38720002-B33601CB-0F1F-40CC-9661-54A9E61520B3Q38822626-BF0B3F6F-1D83-4974-A00D-3B26852E855FQ39027831-82FB2A33-09C8-4AF5-8533-39F8341FCA02Q41149927-4979F27E-CCD3-494C-926F-2BAACEF45F4D
P2860
Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Axon guidance and synaptic mai ...... ative disease and therapeutics
@ast
Axon guidance and synaptic mai ...... ative disease and therapeutics
@en
Axon guidance and synaptic mai ...... ative disease and therapeutics
@nl
type
label
Axon guidance and synaptic mai ...... ative disease and therapeutics
@ast
Axon guidance and synaptic mai ...... ative disease and therapeutics
@en
Axon guidance and synaptic mai ...... ative disease and therapeutics
@nl
prefLabel
Axon guidance and synaptic mai ...... ative disease and therapeutics
@ast
Axon guidance and synaptic mai ...... ative disease and therapeutics
@en
Axon guidance and synaptic mai ...... ative disease and therapeutics
@nl
P2093
P2860
P1476
Axon guidance and synaptic mai ...... ative disease and therapeutics
@en
P2093
Demetrius M Maraganore
Timothy G Lesnick
P2860
P304
P356
10.1016/J.TINS.2008.11.006
P50
P577
2009-01-21T00:00:00Z